Medicamen Biotech Limited (BOM:531146)
India · Delayed Price · Currency is INR 238.75
-3.45 (-1.42%)
At close: Jul 27, 2026
Medicamen Biotech Market Cap
Medicamen Biotech has a market cap or net worth of 3.04 billion as of July 28, 2026. Its market cap has decreased by -38.64% in one year.
Market Cap
3.04B
Enterprise Value
3.20B
Revenue
2.01B
Ranking
n/a
PE Ratio
33.59
Stock Price
238.75
ChartMarket Cap Chart
Since January 12, 2005, Medicamen Biotech's market cap has increased from 108.49M to 3.04B, an increase of 2,698.09%. That is a compound annual growth rate of 16.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 3.04B | -34.24% |
| Dec 31, 2025 | 4.62B | -28.94% |
| Dec 31, 2024 | 6.50B | -14.77% |
| Dec 29, 2023 | 7.62B | -27.09% |
| Dec 30, 2022 | 10.45B | -3.50% |
| Dec 31, 2021 | 10.83B | 86.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jenburkt Pharmaceuticals | 4.64B |
| Albert David | 3.95B |
| BDH Industries | 3.40B |
| Medico Remedies | 3.17B |
| Trident Lifeline | 3.13B |
| Everest Organics | 2.82B |
| Astonea Labs | 2.80B |
| Ambalal Sarabhai Enterprises | 2.49B |